Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

NCT02671890 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped lack of funding

Conditions

Metastatic Pancreatic Adenocarcinoma
Refractory Malignant Solid Neoplasm
Stage IV Pancreatic Cancer AJCC v8

Interventions

DRUG: Chemotherapy
DRUG: Disulfiram
DRUG: Gemcitabine Hydrochloride
OTHER: Laboratory Biomarker Analysis

Sponsor

Mayo Clinic

Collaborators

[object Object]